{"count": 493, "results": [{"_id": "32499908", "pmid": 32499908, "pmcid": "PMC7243386", "title": "Effects of metformin in obesity treatment in different populations: a meta-analysis", "journal": "Ther Adv Endocrinol Metab", "authors": ["Pu R", "Shi D", "Gan T", "Ren X", "Ba Y", "Huo Y", "Bai Y", "Zheng T", "Cheng N"], "date": "2020-05-21T00:00:00Z", "doi": "10.1177/2042018820926000", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "2042018820926000", "score": 50273.508, "text_hl": "This meta-analysis aimed to summarize the @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ quantitatively.", "citations": {"NLM": "Pu R, Shi D, Gan T, Ren X, Ba Y, Huo Y, Bai Y, Zheng T, Cheng N. Effects of metformin in obesity treatment in different populations: a meta-analysis Ther Adv Endocrinol Metab. 2020;11():2042018820926000. PMID: 32499908", "BibTeX": "@article{32499908, title={Effects of metformin in obesity treatment in different populations: a meta-analysis}, author={Pu R and Shi D and Gan T and Ren X and Ba Y and Huo Y and Bai Y and Zheng T and Cheng N}, journal={Ther Adv Endocrinol Metab}, volume={11}, pages={2042018820926000}}"}}, {"_id": "39660840", "pmid": 39660840, "title": "The Effects of Metformin on Weight Loss, Cardiovascular Health, and Longevity.", "journal": "Cardiol Rev", "authors": ["Pillai AA", "Melo L", "Frishman WH", "Aronow WS"], "date": "2024-12-11T00:00:00Z", "doi": "10.1097/CRD.0000000000000832", "meta_date_publication": "2024 Dec 11", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50271.684, "text_hl": "The Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@Weight Loss@@@, Cardiovascular Health, and Longevity.", "citations": {"NLM": "Pillai AA, Melo L, Frishman WH, Aronow WS. The Effects of Metformin on Weight Loss, Cardiovascular Health, and Longevity. Cardiol Rev. 2024 Dec 11;():. PMID: 39660840", "BibTeX": "@article{39660840, title={The Effects of Metformin on Weight Loss, Cardiovascular Health, and Longevity.}, author={Pillai AA and Melo L and Frishman WH and Aronow WS}, journal={Cardiol Rev}}"}}, {"_id": "37466599", "pmid": 37466599, "pmcid": "PMC10352001", "title": "Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups", "journal": "Rev Assoc Med Bras (1992)", "authors": ["Gunay YE", "Kişioğlu SV", "Karakullukçu S", "Tufekcı D", "Demır AS", "Coskun H", "Nuhoglu I", "Kocak M", "Ersöz HÖ"], "date": "2023-07-17T00:00:00Z", "doi": "10.1590/1806-9282.20230174", "meta_date_publication": "2023", "meta_volume": "69", "meta_issue": "7", "meta_pages": "e20230174", "score": 50269.203, "text_hl": "While some studies demonstrate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is neutral on @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@, others state that it has positive aspects. ", "citations": {"NLM": "Gunay YE, Kişioğlu SV, Karakullukçu S, Tufekcı D, Demır AS, Coskun H, Nuhoglu I, Kocak M, Ersöz HÖ. Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups Rev Assoc Med Bras (1992). 2023;69(7):e20230174. PMID: 37466599", "BibTeX": "@article{37466599, title={Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups}, author={Gunay YE and Kişioğlu SV and Karakullukçu S and Tufekcı D and Demır AS and Coskun H and Nuhoglu I and Kocak M and Ersöz HÖ}, journal={Rev Assoc Med Bras (1992)}, volume={69}, number={7}, pages={e20230174}}"}}, {"_id": "34514769", "pmid": 34514769, "pmcid": "PMC10214935", "title": "Metformin - a new approach", "journal": "Pediatr Endocrinol Diabetes Metab", "authors": ["Cwynar-Zając Ł"], "date": "2021-01-01T00:00:00Z", "doi": "10.5114/pedm.2021.107166", "meta_date_publication": "2021", "meta_volume": "27", "meta_issue": "2", "meta_pages": "134-140", "score": 50265.54, "text_hl": "The mean @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated group was higher compared to the untreated control group. ", "citations": {"NLM": "Cwynar-Zając Ł. Metformin - a new approach Pediatr Endocrinol Diabetes Metab. 2021;27(2):134-140. PMID: 34514769", "BibTeX": "@article{34514769, title={Metformin - a new approach}, author={Cwynar-Zając Ł}, journal={Pediatr Endocrinol Diabetes Metab}, volume={27}, number={2}, pages={134-140}}"}}, {"_id": "36806755", "pmid": 36806755, "pmcid": "PMC9938854", "title": "Higher mitochondrial DNA copy number is associated with metformin-induced weight loss", "journal": "Commun Med (Lond)", "authors": ["Wang J", "Liang H", "Huang R", "Weng X", "Zheng L", "Wang Y", "Zheng X", "Gu Z", "Chen F", "Shao J", "Geng Z", "Pearson ER", "Weng J", "Yang W", "Xu T", "Zhou K"], "date": "2023-02-18T00:00:00Z", "doi": "10.1038/s43856-023-00258-0", "meta_date_publication": "2023 Feb 18", "meta_volume": "3", "meta_issue": "1", "meta_pages": "29", "score": 50265.2, "text_hl": "Higher mitochondrial DNA copy number is associated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@", "citations": {"NLM": "Wang J, Liang H, Huang R, Weng X, Zheng L, Wang Y, Zheng X, Gu Z, Chen F, Shao J, Geng Z, Pearson ER, Weng J, Yang W, Xu T, Zhou K. Higher mitochondrial DNA copy number is associated with metformin-induced weight loss Commun Med (Lond). 2023 Feb 18;3(1):29. PMID: 36806755", "BibTeX": "@article{36806755, title={Higher mitochondrial DNA copy number is associated with metformin-induced weight loss}, author={Wang J and Liang H and Huang R and Weng X and Zheng L and Wang Y and Zheng X and Gu Z and Chen F and Shao J and Geng Z and Pearson ER and Weng J and Yang W and Xu T and Zhou K}, journal={Commun Med (Lond)}, volume={3}, number={1}, pages={29}}"}}, {"_id": "37990710", "pmid": 37990710, "pmcid": "PMC10661916", "title": "Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: A single-center study", "journal": "Obes Pillars", "authors": ["Srinivasan D", "Lofton HF"], "date": "2022-04-10T00:00:00Z", "doi": "10.1016/j.obpill.2022.100016", "meta_date_publication": "2022 Jun", "meta_volume": "2", "meta_issue": "", "meta_pages": "100016", "score": 50264.902, "text_hl": "Our study shows improvements in weight with @GENE_GCG @GENE_2641 @@@GLP-1@@@ monotherapy versus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as demonstrated by overall @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ and proportion of @SPECIES_9606 @@@patients@@@ achieving >5% @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@. ", "citations": {"NLM": "Srinivasan D, Lofton HF. Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: A single-center study Obes Pillars. 2022 Jun;2():100016. PMID: 37990710", "BibTeX": "@article{37990710, title={Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: A single-center study}, author={Srinivasan D and Lofton HF}, journal={Obes Pillars}, volume={2}, pages={100016}}"}}, {"_id": "33716960", "pmid": 33716960, "pmcid": "PMC7947603", "title": "Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI >=50 kg/m2 Prior to Bariatric Surgery", "journal": "Front Endocrinol (Lausanne)", "authors": ["Sari C", "Seip RL", "Umashanker D"], "date": "2021-02-25T00:00:00Z", "doi": "10.3389/fendo.2021.588016", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "588016", "score": 50264.074, "text_hl": "(B) A @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ of 18 kg over 6 months of combination therapy with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Topiramate @CHEMICAL_MESH:D000077236 @@@topiramate@@@, prior to laparoscopic sleeve gastrectomy in a 58-year-old @SPECIES_9606 @@@woman@@@. ", "citations": {"NLM": "Sari C, Seip RL, Umashanker D. Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI >=50 kg/m2 Prior to Bariatric Surgery Front Endocrinol (Lausanne). 2021;12():588016. PMID: 33716960", "BibTeX": "@article{33716960, title={Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI >=50 kg/m2 Prior to Bariatric Surgery}, author={Sari C and Seip RL and Umashanker D}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={588016}}"}}, {"_id": "37744021", "pmid": 37744021, "pmcid": "PMC10514453", "title": "Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis", "journal": "Osteoarthr Cartil Open", "authors": ["Cicuttini FM", "Proietto J", "Lim YZ"], "date": "2023-09-09T00:00:00Z", "doi": "10.1016/j.ocarto.2023.100407", "meta_date_publication": "2023 Dec", "meta_volume": "5", "meta_issue": "4", "meta_pages": "100407", "score": 50261.94, "text_hl": "The mechanism for @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ related to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is unclear. ", "citations": {"NLM": "Cicuttini FM, Proietto J, Lim YZ. Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis Osteoarthr Cartil Open. 2023 Dec;5(4):100407. PMID: 37744021", "BibTeX": "@article{37744021, title={Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis}, author={Cicuttini FM and Proietto J and Lim YZ}, journal={Osteoarthr Cartil Open}, volume={5}, number={4}, pages={100407}}"}}, {"_id": "33312159", "pmid": 33312159, "pmcid": "PMC7708317", "title": "GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin", "journal": "Front Endocrinol (Lausanne)", "authors": ["Ouyang J", "Isnard S", "Lin J", "Fombuena B", "Peng X", "Chen Y", "Routy JP"], "date": "2020-11-18T00:00:00Z", "doi": "10.3389/fendo.2020.581839", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "581839", "score": 50261.906, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use has been associated with @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ and it is noteworthy that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-associated @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ was of a lesser extent in non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ people. ", "citations": {"NLM": "Ouyang J, Isnard S, Lin J, Fombuena B, Peng X, Chen Y, Routy JP. GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin Front Endocrinol (Lausanne). 2020;11():581839. PMID: 33312159", "BibTeX": "@article{33312159, title={GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin}, author={Ouyang J and Isnard S and Lin J and Fombuena B and Peng X and Chen Y and Routy JP}, journal={Front Endocrinol (Lausanne)}, volume={11}, pages={581839}}"}}, {"_id": "37347114", "pmid": 37347114, "pmcid": "PMC10280986", "title": "Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial", "journal": "Front Endocrinol (Lausanne)", "authors": ["Wen Q", "Fang S", "Liang Y", "Tian Y", "Chen Y", "Yuan J", "Chen Q"], "date": "2023-06-06T00:00:00Z", "doi": "10.3389/fendo.2023.1156521", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1156521", "score": 50261.168, "text_hl": "Although many studies have confirmed the @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight@@@ reduction effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and GLP-1RA, the potential action of @CHEMICAL_glucagon_like_peptide_1_(7_36) @CHEMICAL_MESH:C061970 @@@beinaglutide@@@ combined with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ versus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alone on @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ has not yet been studied.", "citations": {"NLM": "Wen Q, Fang S, Liang Y, Tian Y, Chen Y, Yuan J, Chen Q. Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial Front Endocrinol (Lausanne). 2023;14():1156521. PMID: 37347114", "BibTeX": "@article{37347114, title={Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial}, author={Wen Q and Fang S and Liang Y and Tian Y and Chen Y and Yuan J and Chen Q}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1156521}}"}}]}